Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Andrée-Laure Herr"'
Autor:
Mustapha Adham, Olivier Berthelet, Isabelle Ray-Coquard, Pierre-Jean Ternamian, Charles Mastier, Bruno Aublet-Cuvellier, Thomas Walter, Yohan Fayet, Christine Rebischung, Bruno Ferroud-Plattet, M. Baconnier, Nicolas Williet, Hélène Labrosse, Christelle De La Fouchardiere, Anne-Marie Marion-Audibert, Pascal Artru, Fadila Farsi, Claude Darcha, Antoine Duclos, Emmanuel Buc, Andrée-Laure Herr, Georges Chambon, Valérie Hervieu
Publikováno v:
Cancers
Volume 13
Issue 14
Cancers, Vol 13, Iss 3515, p 3515 (2021)
Volume 13
Issue 14
Cancers, Vol 13, Iss 3515, p 3515 (2021)
Simple Summary With an increasing incidence, late diagnosis, and high mortality rate, pancreatic adenocarcinoma remains, in 2021, a real challenge for health institutions and professionals worldwide. Despite significant therapeutic progress, the five
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2baa89ee26ec51fa63d3d6e55b7450c
Autor:
Julien Gautier, Anne Sophie Michallet, Olivier Tredan, Amine Belhabri, Souad Assaad, Mehdi Brahmi, Mayeul Tabutin, Armelle Dufresne, J. Fayette, Marie Pierre Steineur, Sylvie Chabaud, Philippe Zrounba, Anne Sophie Erena-Penet, Emmanuelle Nicolas-Virelizier, Pierre Saintigny, Marie Line Fournier, Jean-Yves Blay, Isabelle Ray-Coquard, Aurélien Dupré, Thomas Bachelot, Christelle Galvez, Bénédicte Mastroianni, Philippe Rey, Christelle De La Fouchardiere, Alexandre Basle, Christine Fuhrmann, Lauriane Eberst, V. Avrillon, Andrée Laure Herr, Pierre Roux, Astrid Morel, Marianne Kazes, Franck Pilleul, Amine Bouhamama, Maurice Perol, D. Perol, Gisèle Chvetzoff, Bruno Russias, Philippe A. Cassier, Aurélie Swalduz
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2020, 135, pp.251-259. ⟨10.1016/j.ejca.2020.05.028⟩
European Journal of Cancer, Elsevier, 2020, 135, pp.251-259. ⟨10.1016/j.ejca.2020.05.028⟩
Background Cancer patients presenting with COVID-19 have a high risk of death. In this work, predictive factors for survival in cancer patients with suspected SARS-COV-2 infection were investigated. Methods PRE-COVID-19 is a retrospective study of al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ff1637601c0d8d5888d2e599c5faef9
Autor:
Christina Peters, Yves Bertrand, Eliane Gluckman, Nabil Kabbara, Wagnara Chaves, Karin Tiedemann, Chiara Messina, Irina Ionescu, Vanderson Rocha, Andrée Laure Herr, Samir Kanaan Nabhan, Carmem Bonfim, Cristina Díaz de Heredia, Pierre Teira, Jean Pierre Jouet, Arjan C. Lankester, Franco Locatelli
Publikováno v:
Blood, 116(11), 1849-1856
We analyzed risk factors influencing outcomes after related (R) human leukocyte antigen-identical cord blood transplantation (CBT) for 147 patients with malignancies reported to Eurocord–European Group for Blood and Marrow Transplantation. CBT has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b650cc1f9ca7ad16e8ee795db09c8875
https://doi.org/10.1182/blood-2010-02-271692
https://doi.org/10.1182/blood-2010-02-271692
Autor:
Virginie Gandemer, Gérard Socié, Vanderson Rocha, Thomas Daikeler, Frederica Sora, M. Akif Yesilipek, Ayad Ahmed Hussein, Alessandro Crotta, Annalisa Ruggeri, Anne Sirvent, Jaime Sanz, Valérie Mialou, Marleen Renard, Mario Abinun, Eliane Gluckman, Stefania Varotto, Kristina Carlson, Myriam Labopin, Maura Faraci, Andrée-Laure Herr, Jérôme Cornillon, Caroline A. Lindemans, Ajay Vora, Petr Sedlacek, José Luis Díez-Martín, Anne O'Meara, Dominique Farge, Jan Voswinkel
Publikováno v:
Blood
Blood, American Society of Hematology, 2013, 121 (6), pp.1059--1064. ⟨10.1182/blood-2012-07-445965⟩
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Blood, American Society of Hematology, 2013, 121 (6), pp.1059--1064. ⟨10.1182/blood-2012-07-445965⟩
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
International audience; To describe the incidence, risk factors, and treatment of autoimmune diseases (ADs) occurring after cord blood transplantation (CBT), we analyzed both CBT recipients reported to EUROCORD who had developed at least 1 new AD and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c2f47e634d810c2f61c89b1833009e8
http://hdl.handle.net/10807/39946
http://hdl.handle.net/10807/39946
Autor:
Eliane Gluckman, Andrée-Laure Herr, Duncan Purtill, Vanderson Rocha, Karim Boudjedir, Annalisa Ruggeri, Alessandro Crotta, Irina Ionescu
Publikováno v:
Best practiceresearch. Clinical haematology. 23(2)
Unrelated umbilical cord blood (UCB) has been widely used to treat patients lacking a well-matched HLA donor. Cell dose is a critical determinant of outcomes in cord blood transplantation, limiting the use of this strategy for low body weight patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::460e7a17f9ddf184c7a5b18fe3cf2354
https://pubmed.ncbi.nlm.nih.gov/20837334
https://pubmed.ncbi.nlm.nih.gov/20837334
Autor:
Patricia Ribaud, Raphaël Porcher, Régis Peffault de Latour, Agnès Devergie, Fernando O. Pinto, Andrée-Laure Herr, Anna D. Petropoulou, Philippe Orcel, Thomas Funck Brentano, Gérard Socié, Vanderson Rocha, Marie Robin
Publikováno v:
Transplantation. 89(11)
Bone complications after hematopoietic stem-cell transplantation (HSCT) are relatively frequent. Evaluation of biomarkers of bone turnover and dual energy x-ray absorptiometry (DEXA) are not known in this context.We prospectively evaluated bone miner
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ede16d46ff58ac406098b2d4d5cd8e
https://pubmed.ncbi.nlm.nih.gov/20216480
https://pubmed.ncbi.nlm.nih.gov/20216480
Autor:
Jose Luis Dı́ez, Virginie Gandemer, Amparo Verdeguer, Jan Voswinkel, Charlotte Jubert, Federica Sorà, Alessandro Crotta, Anne O'Meara, Petr Sedlacek, Thomas Daikeler, Hélène Schoemans, Myriam Labopin, Valérie Mialou, Vanderson Rocha, Chiara Messina, Maura Faraci, Andrée-Laure Herr, Anne Sirvent, William Arcese, Annalisa Ruggeri, Dominique Farge, Gérard Socié, Eliane Gluckman, Ajay Vora, M. Akif Yesilipek, Fawzi Abdel-Rahman, Andrew J. Cant
Publikováno v:
Blood. 116:3460-3460
Abstract 3460 Autoimmune diseases (AD) have been reported after haematopoetic stem cell transplantation (HSCT) and most commonly autoimmune cytopenias (AIC) are observed. Proposed risk factors are unrelated donor HSCT and presence of chronic graft-ve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ea4aff0fa111ee3a749cdec42e63eca
https://doi.org/10.1182/blood.v116.21.3460.3460
https://doi.org/10.1182/blood.v116.21.3460.3460
Autor:
Anne Sirvent, Karim Boudjedir, Eliane Gluckman, Vanderson Rocha, William Arcese, Irina Ionescu, Guillermo Sanz, Wagnara Chaves, Renata Bizzetto, Andrée-Laure Herr, Samir Kanaan Nabhan
Publikováno v:
Blood. 112:155-155
Cyclophosphamide (CY) associated to high dose total body irradiation (TBI) or busulfan (BU) is the gold standard of myeloablative conditioning regimen (MAC) in allogeneic hematopoietic stem cell transplantation (HSCT). In unrelated transplants, anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efb3e1b44af112a6a6a7fa00eea424d0
https://doi.org/10.1182/blood.v112.11.155.155
https://doi.org/10.1182/blood.v112.11.155.155
Autor:
Agnès Devergie, Philippe Orcel, Marie Robin, Régis Peffault de Latour, Anna D. Petropoulou, Andrée-Laure Herr, Gérard Socié
Publikováno v:
Blood. 112:2135-2135
Osteoporotic fractures (OF) and avascular necrosis (AN), are major late complications after allogeneic hematopoietic stem cell transplantation (HSCT). We prospectively studied bone complications (BC) after HSCT. Patients and Methods: Pts having recei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5fc3c49e848a11eaafb4623fc3316ca0
https://doi.org/10.1182/blood.v112.11.2135.2135
https://doi.org/10.1182/blood.v112.11.2135.2135
Autor:
Christelle Ferra, Lucilla Lecchi, Roelof Willemze, Gesine Koegler, Celso Arrais Rodrigues, Timothy Devos, Anne Sirvent, Guillermo Sanz, Irina Ionescu, Federico Garnier, Andrée-Laure Herr, Gérard Socié, Karim Boudjedir, Vanderson Rocha, Bernard Rio, Marc Renaud, Yves Beguin, Mohamad Mohty, Myriam Labopin, Eliane Gluckman, Gérard Michel, Luis Madero, Juan Carlos Camargo García, Cristina Navarrete
Publikováno v:
Blood. 112:156-156
HLA class I, killer-cell immunoglobulin-like receptor (KIR) ligands which are missing in the recipient may trigger cytotoxicity of donor NK cells leading to graft-versus- host disease (GvHD) and/or graft-versus-leukemia reactions. Donor KIR(-ligand)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acefdbdd7648ed2e4aabce52ef350a0f
https://doi.org/10.1182/blood.v112.11.156.156
https://doi.org/10.1182/blood.v112.11.156.156